Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:52 PM
Ignite Modification Date:
2025-12-24 @ 5:52 PM
NCT ID:
NCT00002668
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Recurrent or metastatic breast or prostate cancer
* "Pain worst" score of 4 or greater on the Brief Pain Inventory
* No prior enrollment on this study (patients treated during the run-in period are ineligible for randomization)
* Hormone receptor status:
* Not specified
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Menopausal status:
* Not specified
Performance status:
* ECOG 0-2
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* No major psychiatric illness, including the following DSM-III-R diagnoses:
* Bipolar disorder
* Schizophrenia
* Major depression
* Multiple personality disorder
* Psychotic disorder
* Dementia
* Outpatient status required
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* Not specified
Endocrine therapy:
* Not specified
Radiotherapy:
* At least 28 days since prior palliative radiotherapy to major site(s) of pain
Surgery:
* Greater than 30 days since prior surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00002668
Study Brief:
Protocol Section:
NCT00002668